Skip to main content
. 2022 May 11;205:111684. doi: 10.1016/j.mad.2022.111684

Table 1.

Characteristics of study participants according to vitamin D status.a.

Characteristics Whole sample (n = 681) Serum vitamin D
p
Normal (n = 452) Deficient (n = 229)
General and clinical characteristics
Age (years) 53.4 ± 15.2 52.2 ± 15.0 55.8 ± 15.3 0.004
Sex (female) 335 (49) 233 (52) 102 (44) 0.05
Education (years) 14.5 ± 4.4 14.8 ± 3.8 13.9 ± 4.4 0.009
Physically active 374 (56) 266 (60) 108 (48) 0.003
Hypertension 203 (29) 121 (26) 82 (36) 0.01
Heart failure 17 (3) 8 (2) 9 (4) 0.07
Diabetes 51 (7) 20 (4) 31 (13) < 0.001
Renal failure 21 (3) 8 (2) 13 (5) 0.007
COPD 54 (8) 28 (6) 26 (11) 0.01
Cancer 15 (2) 9 (2) 6 (3) 0.39
BMI (kg/m2) 25.7 ± 4.4 25.2 ± 4.3 26.7 ± 4.4 < 0.001
Severity of acute COVID-19
No hospitalization 285 (41) 210 (47) 73 (32) < 0.001
Hospitalization - no O2 supplementation 114 (17) 71 (16) 42 (19)
Hospitalization - low-flow O2 supplementation 176 (26) 112 (25) 65 (28)
Hospitalization - NIV or IV 106 (16) 59 (13) 49 (21)
Length of hospital stay (days) 16.8 ± 13.9 16.9 ± 14.6 16.6 ± 12.7 0.85
Blood parameters
Albumin (g/L) 42.7 ± 3.2 43.1 ± 3.0 42.1 ± 3.5 < 0.001
Hemoglobin (g/dL) 13.8 ± 1.4 13.8 ± 1.4 13.8 ± 1.5 0.52
25-OH vitamin D (ng/mL) 25.6 ± 12.2 31.1 ± 11.2 14.8 ± 4.6 < 0.001
CRP (mg/L) 2.4 ± 5.4 2.0 ± 4.4 3.3 ± 7.0 < 0.001

BMI: body mass index; COPD: chronic obstructive pulmonary disease; CRP: C-reactive protein; IV: invasive ventilation; NIV: non-invasive ventilation.

a

Data are given as number (percentage) for sex, physical activity, diseases, and categories of COVID-19 severity; for all other variables, means ± standard deviations are reported.